Teleflex Incorporated (NYSE:TFX – Get Free Report) reached a new 52-week low during trading on Thursday . The stock traded as low as $167.78 and last traded at $168.28, with a volume of 488076 shares traded. The stock had previously closed at $171.31.
Wall Street Analysts Forecast Growth
TFX has been the subject of a number of recent analyst reports. Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. Truist Financial lowered their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research report on Wednesday, December 18th. Mizuho cut their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Finally, StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $252.50.
Get Our Latest Stock Report on Teleflex
Teleflex Stock Down 1.8 %
Institutional Inflows and Outflows
Institutional investors have recently made changes to their positions in the stock. Headlands Technologies LLC purchased a new stake in Teleflex in the 4th quarter worth approximately $29,000. Cromwell Holdings LLC boosted its position in shares of Teleflex by 59.0% in the third quarter. Cromwell Holdings LLC now owns 132 shares of the medical technology company’s stock worth $33,000 after purchasing an additional 49 shares during the period. Avior Wealth Management LLC increased its stake in shares of Teleflex by 190.6% in the third quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 101 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in shares of Teleflex during the 3rd quarter valued at $40,000. Finally, True Wealth Design LLC lifted its stake in shares of Teleflex by 16,600.0% during the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.
Teleflex Company Profile
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
See Also
- Five stocks we like better than Teleflex
- 3 Fintech Stocks With Good 2021 Prospects
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Golden Cross Stocks: Pattern, Examples and Charts
- Inflation Persists, But So Do Stock Opportunities: Rally On
- Following Congress Stock Trades
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.